Item 3. Source and Amount of Funds or Other Consideration.
The amount of funds expended by Cryo-Cell to acquire the 110,749,924 of Common Stock it holds in its name is $276,752 .
Do the math, .0024 @ shr
Item 4. Purpose of Transaction.
Cryo-Cell’s purpose in acquiring shares of Common Stock of CBAI is to benefit from any future appreciation in the stock price of CBAI, and potentially to influence the future direction of CBAI.
As Cryo-Cell disclosed in a current report on Form 8-K filed on March 10, 2015 with the Securities and Exchange Commission, on March 10, 2015, Cryo-Cell filed a lawsuit in the Pinellas County Court, Florida in order to compel CBAI to hold an annual meeting of shareholders for the purpose of electing directors. On May 8, 2015, CBAI filed a Form 8-K with the Securities and Exchange Commission announcing that CBAI would hold an annual meeting of shareholders on July 14, 2015 to, amongst other matters, elect directors.
In the fourth quarter of 2014, Cryo-Cell conducted due diligence on CBAI and was in negotiations at that time with CBAI to engage in a business combination with, or make a capital investment in, CBAI.
Cryo-Cell is considering entering into a confidentiality agreement with the Issuer with regard to exploring the possible acquisition of CBAI by Cryo-Cell.
Subject to availability at prices deemed favorable, Cryo-Cell may acquire additional shares of Common Stock of CBAI from time to time in the open market, in privately negotiated transactions, or otherwise. Cryo-Cell may also dispose of shares of Common Stock of CBAI from time to time in the open market, in privately negotiated transactions, or otherwise. Cryo-Cell or persons affiliated therewith may also enter into transactions directly with CBAI with respect to the acquisition or disposition of shares, or otherwise.
Looks to me like Red Oak stepped on CCEL's shoes....the result of that imo is a hostile trading environment that CCEL can do forever.
News 
Market Data 
Discover 
